Newsfeeds - Spark Newswire

2 minute read

OptimizeRx Announces Results From Its Use Of Previously Announced AI/RWE Solution

Today, 2:15 PM

ROCHESTER, Mich., Oct. 11, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on

OPRX

1 minute read

OptimizeRx Extends Exclusive Partnership With Therapy Brands

By Benzinga Newsdesk

Today, 2:15 PM

Innovative best-in-class technology solutions continue to offer HCPs a seamless prescribing experience within the EHR workflow

OPRX

1 minute read

Here’s How Much $100 Invested In OptimizeRx 5 Years Ago Would Be Worth Today

By Benzinga Insights

Today, 2:15 PM

OptimizeRx (NASDAQ:OPRX) has outperformed the market over the past 5 years by 54.86% on an annualized basis producing an average annual return of 66.88%. Currently, OptimizeRx has a market capitalization of $279.90 million.

OPRX

8 minute read

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:15 PM

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

ABCL

3 minute read

Nasdaq Surges Over 300 Points; Trade Desk Shares Spike Higher

By Lisa Levin

Today, 2:15 PM

U.S. stocks traded higher toward the end of trading, following the release of inflation data.

AMRS

5 minute read

Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 2:15 PM

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.

ABCL

1 minute read

WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday

By Lisa Levin

Today, 2:15 PM

OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.

ALC

1 minute read

RBC Capital Maintains Outperform on OptimizeRx, Lowers Price Target to $22

By Benzinga Newsdesk

Today, 2:15 PM

RBC Capital analyst Sean Dodge maintains OptimizeRx (NASDAQ:OPRX) with a Outperform and lowers the price target from $50 to $22.

OPRX

3 minute read

Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket

By Lisa Levin

Today, 2:15 PM

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.

ABCL

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 2:15 PM

AEMD